Covid-19 Impact on Bionic Limbs Market, Global Research Reports 2020-2021
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Bionic Limbs Quarterly Market Size Analysis
- 2.1 Bionic Limbs Business Impact Assessment - COVID-19
- 2.1.1 Global Bionic Limbs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Bionic Limbs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Bionic Limbs Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Bionic Limbs Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Bionic Limbs Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Bionic Limbs Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Bionic Limbs Market
- 3.5 Key Manufacturers Bionic Limbs Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Bionic Limbs Segments, By Type
- 4.1 Introduction
- 1.4.1 Bionic Legs
- 1.4.2 Bionic Hands
- 4.2 By Type, Global Bionic Limbs Market Size, 2019-2021
- 4.2.1 By Type, Global Bionic Limbs Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Bionic Limbs Price, 2020-2021
5 Impact of Covid-19 on Bionic Limbs Segments, By Application
- 5.1 Overview
- 5.5.1 Hospital
- 5.5.2 Clinic
- 5.5.3 Others
- 5.2 By Application, Global Bionic Limbs Market Size, 2019-2021
- 5.2.1 By Application, Global Bionic Limbs Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Bionic Limbs Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Abiomed Inc.
- 7.1.1 Abiomed Inc. Business Overview
- 7.1.2 Abiomed Inc. Bionic Limbs Quarterly Production and Revenue, 2020
- 7.1.3 Abiomed Inc. Bionic Limbs Product Introduction
- 7.1.4 Abiomed Inc. Response to COVID-19 and Related Developments
- 7.2 Activelink
- 7.2.1 Activelink Business Overview
- 7.2.2 Activelink Bionic Limbs Quarterly Production and Revenue, 2020
- 7.2.3 Activelink Bionic Limbs Product Introduction
- 7.2.4 Activelink Response to COVID-19 and Related Developments
- 7.3 Advanced Bionics
- 7.3.1 Advanced Bionics Business Overview
- 7.3.2 Advanced Bionics Bionic Limbs Quarterly Production and Revenue, 2020
- 7.3.3 Advanced Bionics Bionic Limbs Product Introduction
- 7.3.4 Advanced Bionics Response to COVID-19 and Related Developments
- 7.4 Alterg
- 7.4.1 Alterg Business Overview
- 7.4.2 Alterg Bionic Limbs Quarterly Production and Revenue, 2020
- 7.4.3 Alterg Bionic Limbs Product Introduction
- 7.4.4 Alterg Response to COVID-19 and Related Developments
- 7.5 Axosuits
- 7.5.1 Axosuits Business Overview
- 7.5.2 Axosuits Bionic Limbs Quarterly Production and Revenue, 2020
- 7.5.3 Axosuits Bionic Limbs Product Introduction
- 7.5.4 Axosuits Response to COVID-19 and Related Developments
- 7.6 Bae Systems
- 7.6.1 Bae Systems Business Overview
- 7.6.2 Bae Systems Bionic Limbs Quarterly Production and Revenue, 2020
- 7.6.3 Bae Systems Bionic Limbs Product Introduction
- 7.6.4 Bae Systems Response to COVID-19 and Related Developments
- 7.7 Bionx Medical Technologies
- 7.7.1 Bionx Medical Technologies Business Overview
- 7.7.2 Bionx Medical Technologies Bionic Limbs Quarterly Production and Revenue, 2020
- 7.7.3 Bionx Medical Technologies Bionic Limbs Product Introduction
- 7.7.4 Bionx Medical Technologies Response to COVID-19 and Related Developments
- 7.8 B-Temia
- 7.8.1 B-Temia Business Overview
- 7.8.2 B-Temia Bionic Limbs Quarterly Production and Revenue, 2020
- 7.8.3 B-Temia Bionic Limbs Product Introduction
- 7.8.4 B-Temia Response to COVID-19 and Related Developments
- 7.9 Bana Teknoloji
- 7.9.1 Bana Teknoloji Business Overview
- 7.9.2 Bana Teknoloji Bionic Limbs Quarterly Production and Revenue, 2020
- 7.9.3 Bana Teknoloji Bionic Limbs Product Introduction
- 7.9.4 Bana Teknoloji Response to COVID-19 and Related Developments
- 7.10 Bionik Laboratories
- 7.10.1 Bionik Laboratories Business Overview
- 7.10.2 Bionik Laboratories Bionic Limbs Quarterly Production and Revenue, 2020
- 7.10.3 Bionik Laboratories Bionic Limbs Product Introduction
- 7.10.4 Bionik Laboratories Response to COVID-19 and Related Developments
- 7.11 Bioservo Technologies
- 7.11.1 Bioservo Technologies Business Overview
- 7.11.2 Bioservo Technologies Bionic Limbs Quarterly Production and Revenue, 2020
- 7.11.3 Bioservo Technologies Bionic Limbs Product Introduction
- 7.11.4 Bioservo Technologies Response to COVID-19 and Related Developments
- 7.12 Carmat
- 7.12.1 Carmat Business Overview
- 7.12.2 Carmat Bionic Limbs Quarterly Production and Revenue, 2020
- 7.12.3 Carmat Bionic Limbs Product Introduction
- 7.12.4 Carmat Response to COVID-19 and Related Developments
- 7.13 Cleveland Fes Center
- 7.13.1 Cleveland Fes Center Business Overview
- 7.13.2 Cleveland Fes Center Bionic Limbs Quarterly Production and Revenue, 2020
- 7.13.3 Cleveland Fes Center Bionic Limbs Product Introduction
- 7.13.4 Cleveland Fes Center Response to COVID-19 and Related Developments
- 7.14 COAPT
- 7.14.1 COAPT Business Overview
- 7.14.2 COAPT Bionic Limbs Quarterly Production and Revenue, 2020
- 7.14.3 COAPT Bionic Limbs Product Introduction
- 7.14.4 COAPT Response to COVID-19 and Related Developments
- 7.15 Cochlear
- 7.15.1 Cochlear Business Overview
- 7.15.2 Cochlear Bionic Limbs Quarterly Production and Revenue, 2020
- 7.15.3 Cochlear Bionic Limbs Product Introduction
- 7.15.4 Cochlear Response to COVID-19 and Related Developments
- 7.16 Cyberdyne
- 7.16.1 Cyberdyne Business Overview
- 7.16.2 Cyberdyne Bionic Limbs Quarterly Production and Revenue, 2020
- 7.16.3 Cyberdyne Bionic Limbs Product Introduction
- 7.16.4 Cyberdyne Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Bionic Limbs Supply Chain Analysis
- 8.1.1 Bionic Limbs Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Bionic Limbs Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Bionic Limbs Distribution Channels
- 8.2.2 Covid-19 Impact on Bionic Limbs Distribution Channels
- 8.2.3 Bionic Limbs Distributors
- 8.3 Bionic Limbs Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Bionic Limbs, including the following market information:
Global Bionic Limbs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Bionic Limbs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Bionic Limbs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Bionic Limbs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Abiomed Inc., Activelink, Advanced Bionics, Alterg, Axosuits, Bae Systems, Bionx Medical Technologies, B-Temia, Bana Teknoloji, Bionik Laboratories, Bioservo Technologies, Carmat, Cleveland Fes Center, COAPT, Cochlear, Cyberdyne, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Bionic Legs
Bionic Hands
Based on the Application:
Hospital
Clinic
Others